Silencing MSR1 in Macrophages Attenuates the Cochlear Foreign Body Response and Preserves Electrode–Neural Interface

Abstract Cochlear implantation (CI) provides effective auditory rehabilitation for patients with severe-to-profound sensorineural hearing loss. Implantation can nevertheless induce local foreign body response (FBR) and cochlear fibrosis, motivating strategies to reduce tissue reactions and preserve cochlear integrity. Macrophages play a key role in FBR, but their functions are multiple and stage-dependent, and indiscriminate intervention may aggravate cochlear injury. Therefore, more precise strategies are needed to modulate macrophage-mediated FBR after CI. Here, through transcriptomic profiling of cochlear tissues from rats 30 days after cochlear implantation, we identified macrophage scavenger receptor 1 (MSR1) as a prominent signature after CI. In vitro assays further verified the role of MSR1 in reshaping macrophage phenotype and inflammatory activation. To achieve targeted MSR1 regulation in the cochlea, we engineered iRGD-modified extracellular vesicles to deliver siMSR1 (iRGD-EV/siMSR1). iRGD modification enhanced macrophage uptake of EV and enabled efficient siRNA delivery. In a rat CI model, local administration of iRGD-EV/siMSR1 reduced cochlear fibrotic tissue formation and decreased fibrosis-related protein expression. Moreover, iRGD-EV/siMSR1 preserved spiral ganglion neurons and myelin structures, contributing to residual hearing protection after implantation. Early stage analysis at 7 days after implantation showed that iRGD-EV/siMSR1 suppressed macrophage inflammatory activation, reduced TGF-β1-related profibrotic signaling, regulated matrix remodeling, and limited early apoptosis. These findings identify MSR1 as a promising molecular target for cochlear implant-induced FBR and support iRGD-EV/siMSR1 as a potentially translatable strategy for attenuating cochlear fibrosis and preserving the cochlear neural interface, also highlighting the importance of considering neural health when modulating macrophage-mediated responses to cochlear implants.

Authors

Institutions

Publication Details

Journal
ACS Nano
Published
2026-11-12
DOI
https://doi.org/10.1021/acsnano.6c16644
Primary Topic
Hearing Loss and Rehabilitation
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Silencing MSR1 in Macrophages Attenuates the Cochlear Foreign Body Response and Preserves Electrode–Neural Interface

Jie Tang, Andrej Kral, Hongzheng Zhang, Yongdong Lin et al.
ACS Nano
Hearing Loss and Rehabilitation
article

Silencing MSR1 in Macrophages Attenuates the Cochlear Foreign Body Response and Preserves Electrode–Neural Interface

Jie Tang, Andrej Kral, Hongzheng Zhang, Yongdong Lin, Yunyou You, Jing Pan, Jie Yang, Ying Zhang, Anning Chen, Qing Peng
article en

Abstract

Abstract Cochlear implantation (CI) provides effective auditory rehabilitation for patients with severe-to-profound sensorineural hearing loss. Implantation can nevertheless induce local foreign body response (FBR) and cochlear fibrosis, motivating strategies to reduce tissue reactions and preserve cochlear integrity. Macrophages play a key role in FBR, but their functions are multiple and stage-dependent, and indiscriminate intervention may aggravate cochlear injury. Therefore, more precise strategies are needed to modulate macrophage-mediated FBR after CI. Here, through transcriptomic profiling of cochlear tissues from rats 30 days after cochlear implantation, we identified macrophage scavenger receptor 1 (MSR1) as a prominent signature after CI. In vitro assays further verified the role of MSR1 in reshaping macrophage phenotype and inflammatory activation. To achieve targeted MSR1 regulation in the cochlea, we engineered iRGD-modified extracellular vesicles to deliver siMSR1 (iRGD-EV/siMSR1). iRGD modification enhanced macrophage uptake of EV and enabled efficient siRNA delivery. In a rat CI model, local administration of iRGD-EV/siMSR1 reduced cochlear fibrotic tissue formation and decreased fibrosis-related protein expression. Moreover, iRGD-EV/siMSR1 preserved spiral ganglion neurons and myelin structures, contributing to residual hearing protection after implantation. Early stage analysis at 7 days after implantation showed that iRGD-EV/siMSR1 suppressed macrophage inflammatory activation, reduced TGF-β1-related profibrotic signaling, regulated matrix remodeling, and limited early apoptosis. These findings identify MSR1 as a promising molecular target for cochlear implant-induced FBR and support iRGD-EV/siMSR1 as a potentially translatable strategy for attenuating cochlear fibrosis and preserving the cochlear neural interface, also highlighting the importance of considering neural health when modulating macrophage-mediated responses to cochlear implants.

ACS Nano
Medizinische Hochschule Hannover (DE), Chinese University of Hong Kong, Shenzhen (CN), Southern Medical University (CN)
National Natural Science Foundation of China, China Postdoctoral Science Foundation
Good health and well-being
Hearing Loss and Rehabilitation
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon